Dahl Andrew M.

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 50% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dahl Andrew M.'s trades of Edwards Lifesciences Corporation's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-31
S Sale
53,711 -39.3%
180.72
US$3,577,809 		53,711 -39.3% 180.72 US$3,577,809
2026-08-31 2026-08-31
PrS Proposed sale
42,977
175.31
US$778,243 		42,977 175.31 US$778,243
2026-05-29 2026-05-29
S Sale
47,209 +20.8%
309.64
US$3,736,018 		47,209 +20.8% 309.64 US$3,736,018
2026-05-29 2026-05-29
PrS Proposed sale
568
86.01
US$48,853 		568 86.01 US$48,853